SULJE VALIKKO

avaa valikko

Roger Bertolotti | Akateeminen Kirjakauppa

Haullasi löytyi yhteensä 3 tuotetta
Haluatko tarkentaa hakukriteerejä?



Autologous And Cancer Stem Cell Gene Therapy
Roger Bertolotti; Keiya Ozawa
World Scientific Publishing Co Pte Ltd (2007)
Kovakantinen kirja
241,60
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
PGT 1 BASIC AND CLINICAL FRONTIERS
Roger Bertolotti; Hasan Parvez; Nagatsu
Brill (2000)
Kovakantinen kirja
83,80
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
PIONEERING STEM CELL/GENE THERAPY T
Roger Bertolotti
Brill (2003)
Kovakantinen kirja
243,10
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Autologous And Cancer Stem Cell Gene Therapy
241,60 €
World Scientific Publishing Co Pte Ltd
Sivumäärä: 488 sivua
Asu: Kovakantinen kirja
Julkaisuvuosi: 2007, 19.12.2007 (lisätietoa)
Kieli: Englanti
Stem cells provide for life-long cell replacement in tissues and organs, and have inherent homing abilities that are critical in therapeutic applications. Stem cells are also the driving force of cancer where genetic/epigenetic alterations culminate in tumorigenesis either in tissue stem cells or in some of their derivatives. As a rare subset of the tumor, cancer stem cells are the only drive of tumor initiation/propagation. Autologous and cancer stem cells are thus the key targets of 1) long-term and transient-regenerative/epigenetic gene therapy and 2) of recurrence-free anticancer therapy, respectively. While cancer stem cell gene therapy still needs time to accomplish, autologous stem cells have been instrumental in the first unequivocal successes for gene therapy whereby ex vivo retrovirally corrected hematopoietic stem cells have been returned to the patients.This timely book presents 1) the aforementioned stem cell gene therapy achievements that rely on random-integration of therapeutic transgenes into host chromosomes and 2) emerging experimental approaches aimed at eliminating random-integration oncogenic hazards through site-specific integration or gene targeting. Breakthrough endonuclease-boosted gene targeting for gene correction (inherited diseases) or targeted integration of therapeutic transgenes (other disorders) culminating in an efficiency compatible with clinical trials is one of the highlights of the book. Highlights also include the pioneering transplantation of adult pluripotent stem cells as a substitute for tissue-specific stem cells, thereby pinpointing the invaluable potential for stem cell gene therapy applications of autologous cells able to contribute to all three germ layers. Stem cell gene therapy is thus discussed in terms of 1) magnifying stem cell therapeutic homing through transient regenerative gene therapy and 2) of tackling most pathologies (including mitochondrial DNA diseases and ageing disorders) through stem cell repopulation dynamics into appropriate niches (long-term engraftment) and tissues (cell turn-over). Regarding cancer stem cell gene therapy, focus is on both the increasing number of identified tissue-specific cancer stem cells as the ultimate therapeutic targets and on the development of armed stem cells as tumor-homing vectors for targeted anticancer therapy.

Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tilaustuote | Arvioimme, että tuote lähetetään meiltä noin 3-4 viikossa | Tilaa jouluksi viimeistään 27.11.2024
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Autologous And Cancer Stem Cell Gene Therapyzoom
Näytä kaikki tuotetiedot
ISBN:
9789812775863
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste